SCHEMBL6426893

SCHEMBL6426893

COc1ccc(/C=C/c2n[nH]c3ccc(C(=O)NCc4cnccn4)c(OC)c23)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 6/20 0.39
BRD9 Q9H8M2 1/20 0.37
HPGDS O60760 1/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
SPR P35270 1/20 0.35
MEN1 O00255 1/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 1/20 0.35
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426065 0.94 HPGDS (0.37) TUBB1BRD9HPGDSALDH1A1KDM4E
SCHEMBL13927767 0.94 HPGDS (0.38) BRD9HPGDSALDH1A1KDM4EJAK1
SCHEMBL6428814 0.93 KDM4E (0.43) BRD9HPGDSALDH1A1KDM4EHPGD
SCHEMBL5031205 0.90 HPGDS (0.37) BRD9HPGDSALDH1A1KDM4EJAK1
SCHEMBL13927765 0.90 ALDH1A1 (0.48) ALDH1A1KDM4EJAK1TYK2SMN1; SMN2
SCHEMBL13927766 0.88 CYP1A2 (0.49) ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1
SCHEMBL6425792 0.87 HPGDS (0.44) HPGDSALDH1A1KDM4ESMN1; SMN2HPGD
SCHEMBL6426121 0.85 HPGDS (0.39) BRD9HPGDSALDH1A1KDM4EJAK1
SCHEMBL4145300 0.85 HPGD (0.50) TUBB1ALDH1A1KDM4ESMN1; SMN2HPGD
SCHEMBL4145292 0.85 HPGD (0.50) TUBB1ALDH1A1KDM4ESMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B TUBB1 1202/4885BRD9 636/4885HPGDS 3567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.